The city of Baltimore, Maryland, currently has 22 active clinical trials seeking participants for Depression research studies.
Change in Social Media Use and Well-being Among College Students Receiving a One-week Exercise or Mindfulness Intervention
Recruiting
The investigators will be randomizing 150 college student participants with high levels of social media use into either a 1) control condition (no intervention), a 2) mindfulness meditation cognitive intervention, or 3) a social media reduction + exercise replacement intervention. Participants complete intervention activities daily for one week. The investigators will collect self-report and behavioral measures of social media use and related psychological constructs at three time points: baseli... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/09/2024
Locations: Johns Hopkins University, Baltimore, Maryland
Conditions: Social Media Addiction, Depression, Anxiety, Well-Being, Psychological
IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's
Recruiting
The purpose of this study is to assess the efficacy of an oral medication, IGC-AD1 that is a natural THC-based (Tetrahydrocannabinol) formulation, administered in micro doses, twice a day, on symptomatological Agitation, in patients with mild to severe dementia from Alzheimer's.
Gender:
All
Ages:
60 years and above
Trial Updated:
01/05/2024
Locations: Site 400, Baltimore, Maryland
Conditions: Alzheimer Disease, Agitation,Psychomotor, Depression, Anxiety, Memory Impairment, Care Giving Burden, NPS, Agitated; State, Acute Reaction to Stress, Aggression, Aggressive Outburst
Virtual Group Psychoeducational Discussions With Spanish-Speaking Mothers of Infants in Pediatric Primary Care
Recruiting
The goal of the proposed research is to test the feasibility and acceptability of a virtual group session which is intended to be offered universally to Spanish-speaking parents of newborns/infants attending pediatric primary care. The virtual session is intended to (1) enhance patient/family education about postpartum depression (PPD) and (2) Provide an orientation to families regarding relevant clinic and community psychosocial support resources available. The investigators will conduct a sing... Read More
Gender:
Female
Ages:
Between 16 years and 99 years
Trial Updated:
12/01/2023
Locations: Johns Hopkins Bayview Medical Center, Baltimore, Maryland
Conditions: Postpartum Depression, Postpartum Anxiety
Preventing Postpartum Depression in Immigrant Latinas
Recruiting
Postpartum depression (PPD) affects 10-20% of women, with immigrant Latinas disproportionately affected. PPD prevention and treatment is limited among immigrant Latinas due to an array of structural and cultural factors, suggesting the need to deliver interventions outside of traditional healthcare settings. Virtual interventions have the potential to reduce barriers to mental health services for immigrant Latinas, but there is little research on the effectiveness of virtual interventions to red... Read More
Gender:
Female
Ages:
16 years and above
Trial Updated:
10/30/2023
Locations: Johns Hopkins University School of Medicine, Baltimore, Maryland
Conditions: Postpartum Depression
Pain Reduction Through Empowered Recovery (PRIME) Study
Recruiting
Chronic pain and depression or low mood are often experience by women who age with or into disabilities. Due to various factors women with disabilities often experience this cycle of pain and depression. Both of these conditions can be debilitating and lead to declines in health. Treating these conditions simultaneously, particularly , in older adults can be complicated due to side effects, risks of poor access to pain management and mental health care , and complications from other co occuring... Read More
Gender:
Female
Ages:
50 years and above
Trial Updated:
08/11/2023
Locations: Johns Hopkins School of Nursing, Baltimore, Maryland
Conditions: Pain, Chronic, Depressive Symptoms, Depression, Disability Physical
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Recruiting
This open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocybin may improve quality of life in those individuals.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
08/09/2023
Locations: Behavioral Pharmacology Research Unit, Baltimore, Maryland
Conditions: Depressive Symptoms, Depression, Alzheimer Disease, Mild Cognitive Impairment
A Study of Pregnant and Postpartum Women With and Without Mood Disorders
Recruiting
This study is looking at genetic, biological, and environmental causes and how all three may work together to cause postpartum mood episodes. Participants will have psychiatric histories taken and will be monitored throughout pregnancy and during the postpartum period for the development of depressive or other mood episodes. Biological measures, including hormone levels, immunological measures, and growth factors will be collected. Environmental factors such as sleep deprivation and stress will... Read More
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
05/30/2023
Locations: 550 North Broadway, Baltimore, Maryland
Conditions: Bipolar Disorder, Major Depressive Disorder, Postpartum Depression, Postpartum Psychosis
Glucose Variability and Cognition in Prediabetes
Recruiting
This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.
Gender:
All
Ages:
50 years and above
Trial Updated:
05/15/2023
Locations: Baltimore VA Geriatric Research Education and Clinical Center (GRECC), Baltimore, Maryland
Conditions: Glucose Metabolism Disorders (Including Diabetes Mellitus), Cognitive Decline, Functional Status, PreDiabetes, Aging, Depression
The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes
Recruiting
The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression).
Gender:
All
Ages:
18 years and above
Trial Updated:
03/23/2022
Locations: Aaronson, Baltimore, Maryland
Conditions: Treatment Resistant Depression
Online System for Identifying and Addressing Teen Depression in Primary Care
Recruiting
A novel web-based module (Teen Depression Module or TDM)has been created for assisting primary care providers (PCPs) in screening for and addressing and referring teens with depression. This is a cluster randomized Quality Improvement study to determine if use of the TDM that includes collecting information on strengths and goals as part of well child care will improve detection of depression, referral success, and teen's use of alternative helping strategies with resulting improvement in depres... Read More
Gender:
All
Ages:
Between 12 years and 99 years
Trial Updated:
03/20/2022
Locations: Total Child Health, Baltimore, Maryland
Conditions: Major Depression, Dysthymia, Depressive Symptoms